The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 31 | — | 20.1x | Below average | |
Growth | 62 | 44.1% | 5.6% | Near average | |
Quality | 40 | -90.0% | 7.6% | Near average | |
Safety | 58 | 0.6x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 22 | — | — | Below average | |
Sentiment | 34 | — | — | Below average |
Upstream Bio, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Upstream Bio, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The price forecast for Upstream Bio has stabilized at an average target of 33 dollars, representing a significant premium compared to the current price of 7.63 dollars. The data shows a sharp Dispersion among analysts, with estimates ranging between 15 and 51 dollars, reflecting a high state of uncertainty regarding the company's future operational results, despite the consensus remaining steady over the last 30 days.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.